hMPV Antivirals
Treatment of human Metapneumovirus infection
Not Disclosed/Partner DependentActive
Key Facts
Indication
Treatment of human Metapneumovirus infection
Phase
Not Disclosed/Partner Dependent
Status
Active
Company
About Vironovative
ViroNovative is a private, pre-revenue biotech firm with a singular focus on addressing the unmet medical need posed by human Metapneumovirus (hMPV). Its strategy is built on owning and licensing core patents related to the virus, discovered at Erasmus MC in 2001, and co-developing a full spectrum of countermeasures—from diagnostics to therapeutics—with industrial partners. Led by a seasoned entrepreneur and closely tied to leading academic virology research, the company aims to generate economic value through its extensive IP portfolio and partnership model rather than internal late-stage development.
View full company profile